Boundless Bio, Inc.
Boundless Bio, Inc. (BOLD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BOLD · as of Jun 9, 2026
Key Statistics
Explore Boundless Bio, Inc. Data
bold stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 20 · Buy rate: 30.0%
Competitors & Peers
bold competitorsBOLD
ANTX
INTS
ITRM
NXTC
PLURStock Performance
Full HistoryAbout Boundless Bio, Inc.
Boundless Bio, Inc. a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Th…
what is boundless bio, inc. · bold stock overview · boundless bio, inc. company profile · who is boundless bio, inc. ceo · bold NASDAQ · boundless bio, inc. headquarters · boundless bio, inc. business segments
About Stock Overview & Key Data
Boundless Bio, Inc. (BOLD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 20, 2016. As of the latest trading session, BOLD stock price is $1.43, with a market capitalization of $32.1M. The stock has returned +30.00% over the past 12 months and +19.17% year-to-date.
According to 20 Wall Street analysts, the consensus rating for Boundless Bio, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Boundless Bio, Inc. reported revenue of — and net income of -$58.2M. For detailed data — including Boundless Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Boundless Bio, Inc. (BOLD) stock price is $1.43. The stock is traded on NASDAQ under the ticker symbol BOLD. The 52-week range is $0.96 – $1.68.